Falcon Oil & Gas Court Deadline Looms as Lamesa Holding Opposition Puts C$0.2154 Arbitrage at Risk

The market has already priced in a high probability of this deal closing. The overwhelming shareholder vote last month was a clear signal of that consensus. On March 11, Falcon's shareholders approved the transaction with Tamboran by a margin of approximately 99.76%. That near-unanimous backing, which easily cleared the required thresholds, removed a major overhang and cemented the deal's path forward in the eyes of investors.

The valuation attached to that approval sets the baseline expectation. The deal values Falcon's subsidiaries at C$239 million, which represents a 19.7% premium to Falcon's share price on September 29, 2025. More strikingly, the implied offer price of C$0.2154 per share reflects a 53.2% premium to the 90-day traded volume-weighted average price. This isn't a marginal offer; it's a substantial premium that the market has already accepted as the fair value for the transaction.

Put simply, the expectation gap has closed. The stock price has likely already reflected this premium valuation and the high likelihood of shareholder approval. The remaining hurdles-court approval and other closing conditions-are now the focus, but the core deal terms and their acceptance by Falcon's owners are no longer in question. The market's bet is that the deal will proceed as structured.

The Expectation Gap: Court Delay and the March 30 Deadline

The deal's path is now clear, but the final hurdle is a contested court hearing. The market had priced in shareholder approval and the premium valuation. What remains is a specific, delayed catalyst that creates the current expectation gap: the Supreme Court of British Columbia's final order.

The hearing was adjourned from March 13 to March 24 because a key shareholder, Lamesa Holding S.A., opposed the deal and appeared at the initial session. This opposition introduced a new layer of uncertainty. The company's own update notes there is significant uncertainty as to whether the Final Order will be obtained in a timely manner or at all. The March 24 hearing is the next test, but the outcome is not guaranteed.

This sets up a hard deadline. The arrangement agreement includes a termination date of March 30, 2026. If the Final Order isn't secured by then, or if any other closing condition fails, either party can walk away. The primary risk is that Lamesa's opposition could delay the Final Order further or even block it, forcing a termination. This creates a clear gap between the priced-in approval and the pending, unresolved court decision.

The arbitrage opportunity hinges on this timeline. The stock price likely reflects the high probability of a deal closing. But the March 30 deadline is a tangible, hard stop. If the court delays again or issues an order with conditions that complicate the NYSE listing or trigger a material adverse change clause, the deal could still fall apart. The expectation gap is now about timing and court risk, not deal terms.

The Arbitrage Opportunity: Scenarios for Court Approval

The market's next move depends entirely on the court's decision on March 24. The two potential outcomes create starkly different scenarios, each with a clear market implication. The stock price will now be a direct reflection of which path the court takes.

If the court grants the Final Order on schedule, the deal is almost certainly going to close before the March 30 deadline. The company's own update states it anticipates completion shortly following the final Court hearing. With the premium valuation already priced in and shareholder approval secured, a smooth court approval would simply remove the final overhang. The stock would likely trade at or near the C$0.2154 offer price, validating the expectation that the deal will proceed as planned. This would be a classic "buy the rumor, sell the news" setup in reverse-a clean execution of the already-expected plan.

The more volatile scenario is a denial or further delay. The arrangement agreement gives either party the right to terminate if the deal isn't completed by March 30, 2026. If the court's decision fails to meet the whisper number of a simple, uncontested approval, the deal could still fall apart. In that case, the premium vanishes overnight. The stock would revert to trading on Falcon's standalone fundamentals, likely at a significant discount to the offer price. This would trigger a sharp "sell the news" dynamic, where the market rapidly unwinds the arbitrage trade.

The bottom line is that the court's decision is the final priced-in variable. The market has bet on a deal closing. The March 24 hearing is the test. Any deviation from a clean, favorable order introduces the risk of termination and a swift repricing. The arbitrage opportunity, therefore, is not in the deal's terms but in the court's timing and outcome.

What the Market Might Be Missing: Overlooked Risks and Catalysts

The market's focus is rightly on the court's decision. But a deeper look reveals secondary factors that could influence the outcome or the deal's value post-close. These are the overlooked risks and catalysts that could create a new expectation gap.

First, consider the scale of the combined entity. The deal creates a company with a pro forma market capitalization of >US$500 million. This isn't a minor consolidation; it's a major player in the Beetaloo Basin. The market's bet is that this size and the combined acreage will drive value. Yet the success of that bet hinges entirely on integration. The deal's logic rests on Falcon's assets being successfully woven into Tamboran's existing operations. Any friction in that process, or doubts about the combined entity's ability to execute, could undermine the premium valuation over time. The court might see this as a complex integration risk, though it's not a direct legal ground for denial.

Second, the March 24 hearing is the immediate catalyst, but the termination clause is the hard stop. The arrangement agreement gives either party the right to walk away if the deal isn't completed by March 30, 2026. A denial or a delay that pushes completion past that date triggers termination. This isn't just a formality; it's a material event that would instantly reset the expectation. The stock price would have to repriced to reflect the failure of the premium deal, reverting to Falcon's standalone value. The market must price in the risk that the court's decision, however it comes, fails to clear this final hurdle.

Finally, there's a potential reputational risk that the court could cite. The opposition from Lamesa Holding S.A. introduces a layer of shareholder conflict. The court might consider whether the deal's approval is truly in the best interests of all shareholders, or if it could set a precedent that disadvantages minority voices. While the arrangement agreement includes a "no material adverse change" clause, the court could view ongoing disputes or changes in business partner relationships-like the alignment with Daly Waters Energy-during the process as grounds for delay or denial. This is the kind of intangible risk that isn't priced into the stock's premium but could be a factor in the judge's calculus.

The bottom line is that the arbitrage trade is about timing and a single court decision. But the post-close reality depends on execution, integration, and avoiding any new overhangs. The market is focused on the whisper number of a clean approval. The overlooked risks are the factors that could make that whisper a reality or force a reset.